Text messaging to improve patient adherence in haart: randomized controlled trial
To assess the efficacy of a text messaging (SMS) strategy to improve appointment attendance, treatment adherence, and biological markers (viral load and CD4) in continuous patients with high activity antiretroviral therapy (HAART) who were late to their last scheduled appointment. A randomized contr...
Gespeichert in:
| Veröffentlicht in: | Revista peruana de medicina experimental y salud pública 2019-07, Vol.36 (3), p.400-407 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 407 |
|---|---|
| container_issue | 3 |
| container_start_page | 400 |
| container_title | Revista peruana de medicina experimental y salud pública |
| container_volume | 36 |
| creator | Lizárraga, Iván Renato André Condori Alvirio, Luis Alberto Menacho Pérez-Lu, José Enrique Cavagnaro, César Cárcamo |
| description | To assess the efficacy of a text messaging (SMS) strategy to improve appointment attendance, treatment adherence, and biological markers (viral load and CD4) in continuous patients with high activity antiretroviral therapy (HAART) who were late to their last scheduled appointment.
A randomized controlled trial implemented in Via Libre, a non-governmental organization (NGO) that provides services to people living with human immunodeficiency virus (HIV) in Lima, Peru, was conducted, where 166 follow-up patients were randomized: 82 participants received SMS for six months and 84 participants received standard care.
Patients in the intervention group: 93.9% were men and had a median of 5.1 years in HAART; in the control group: 94.1% were men and a median of 5.3 years in HAART. In the intervention group, patients attended their scheduled medical appointments more frequently than those in the control group (RR=1.89, 95% CI 1.21-2.97) during the six months of intervention. Comparing the viral load level and CD4 level, no differences were found (p=0.930 and p=0.905, respectively). Adherence to treatment measured by self-report was higher in the intervention group (p |
| doi_str_mv | 10.17843/rpmesp.2019.363.4139 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2322138031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2322138031</sourcerecordid><originalsourceid>FETCH-LOGICAL-p561-b82d20a2427d20de90fe112864f4f4ab12c5c2eda4926675b805d7889f2bb3ab3</originalsourceid><addsrcrecordid>eNo1UEtLxDAYDIK46-pPUHL00pp8SdPEmyy-YEGEvZe0-bob6cskK-qvt-DKHGYOM8MwhFxxlvNSS3Ebph7jlAPjJhdK5JILc0KWvASVSSVhQc5jfGesENqYM7IQXDNmBF-Sty1-JTqno935YUfTSH0_hfET6WSTxyFR6_YYcGiQ-oHurQ3pjgY7uLH3P-hoMw4pjF03yxS87S7IaWu7iJdHXpHt48N2_ZxtXp9e1vebbCoUz2oNDpgFCeXMDg1rkXPQSrYzbM2hKRpAZ6UBpcqi1qxwpdamhboWthYrcvNXO4_9OGBMVe9jg11nBxwPsQIBwIVmgs_W66P1UPfoqin43obv6v8F8Qurf19Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2322138031</pqid></control><display><type>article</type><title>Text messaging to improve patient adherence in haart: randomized controlled trial</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lizárraga, Iván Renato André Condori ; Alvirio, Luis Alberto Menacho ; Pérez-Lu, José Enrique ; Cavagnaro, César Cárcamo</creator><creatorcontrib>Lizárraga, Iván Renato André Condori ; Alvirio, Luis Alberto Menacho ; Pérez-Lu, José Enrique ; Cavagnaro, César Cárcamo</creatorcontrib><description>To assess the efficacy of a text messaging (SMS) strategy to improve appointment attendance, treatment adherence, and biological markers (viral load and CD4) in continuous patients with high activity antiretroviral therapy (HAART) who were late to their last scheduled appointment.
A randomized controlled trial implemented in Via Libre, a non-governmental organization (NGO) that provides services to people living with human immunodeficiency virus (HIV) in Lima, Peru, was conducted, where 166 follow-up patients were randomized: 82 participants received SMS for six months and 84 participants received standard care.
Patients in the intervention group: 93.9% were men and had a median of 5.1 years in HAART; in the control group: 94.1% were men and a median of 5.3 years in HAART. In the intervention group, patients attended their scheduled medical appointments more frequently than those in the control group (RR=1.89, 95% CI 1.21-2.97) during the six months of intervention. Comparing the viral load level and CD4 level, no differences were found (p=0.930 and p=0.905, respectively). Adherence to treatment measured by self-report was higher in the intervention group (p<0.001).
The results of this study suggest that sending SMS for six months may improve appointment attendance and adherence to treatment in continuing patients on HAART.</description><identifier>EISSN: 1726-4642</identifier><identifier>DOI: 10.17843/rpmesp.2019.363.4139</identifier><identifier>PMID: 31800931</identifier><language>spa</language><publisher>Peru</publisher><subject>Adolescent ; Adult ; Antiretroviral Therapy, Highly Active - statistics & numerical data ; Appointments and Schedules ; Female ; HIV Infections - blood ; HIV Infections - drug therapy ; Humans ; Male ; Medication Adherence - statistics & numerical data ; Text Messaging ; Young Adult</subject><ispartof>Revista peruana de medicina experimental y salud pública, 2019-07, Vol.36 (3), p.400-407</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31800931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lizárraga, Iván Renato André Condori</creatorcontrib><creatorcontrib>Alvirio, Luis Alberto Menacho</creatorcontrib><creatorcontrib>Pérez-Lu, José Enrique</creatorcontrib><creatorcontrib>Cavagnaro, César Cárcamo</creatorcontrib><title>Text messaging to improve patient adherence in haart: randomized controlled trial</title><title>Revista peruana de medicina experimental y salud pública</title><addtitle>Rev Peru Med Exp Salud Publica</addtitle><description>To assess the efficacy of a text messaging (SMS) strategy to improve appointment attendance, treatment adherence, and biological markers (viral load and CD4) in continuous patients with high activity antiretroviral therapy (HAART) who were late to their last scheduled appointment.
A randomized controlled trial implemented in Via Libre, a non-governmental organization (NGO) that provides services to people living with human immunodeficiency virus (HIV) in Lima, Peru, was conducted, where 166 follow-up patients were randomized: 82 participants received SMS for six months and 84 participants received standard care.
Patients in the intervention group: 93.9% were men and had a median of 5.1 years in HAART; in the control group: 94.1% were men and a median of 5.3 years in HAART. In the intervention group, patients attended their scheduled medical appointments more frequently than those in the control group (RR=1.89, 95% CI 1.21-2.97) during the six months of intervention. Comparing the viral load level and CD4 level, no differences were found (p=0.930 and p=0.905, respectively). Adherence to treatment measured by self-report was higher in the intervention group (p<0.001).
The results of this study suggest that sending SMS for six months may improve appointment attendance and adherence to treatment in continuing patients on HAART.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antiretroviral Therapy, Highly Active - statistics & numerical data</subject><subject>Appointments and Schedules</subject><subject>Female</subject><subject>HIV Infections - blood</subject><subject>HIV Infections - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Text Messaging</subject><subject>Young Adult</subject><issn>1726-4642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UEtLxDAYDIK46-pPUHL00pp8SdPEmyy-YEGEvZe0-bob6cskK-qvt-DKHGYOM8MwhFxxlvNSS3Ebph7jlAPjJhdK5JILc0KWvASVSSVhQc5jfGesENqYM7IQXDNmBF-Sty1-JTqno935YUfTSH0_hfET6WSTxyFR6_YYcGiQ-oHurQ3pjgY7uLH3P-hoMw4pjF03yxS87S7IaWu7iJdHXpHt48N2_ZxtXp9e1vebbCoUz2oNDpgFCeXMDg1rkXPQSrYzbM2hKRpAZ6UBpcqi1qxwpdamhboWthYrcvNXO4_9OGBMVe9jg11nBxwPsQIBwIVmgs_W66P1UPfoqin43obv6v8F8Qurf19Y</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Lizárraga, Iván Renato André Condori</creator><creator>Alvirio, Luis Alberto Menacho</creator><creator>Pérez-Lu, José Enrique</creator><creator>Cavagnaro, César Cárcamo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Text messaging to improve patient adherence in haart: randomized controlled trial</title><author>Lizárraga, Iván Renato André Condori ; Alvirio, Luis Alberto Menacho ; Pérez-Lu, José Enrique ; Cavagnaro, César Cárcamo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p561-b82d20a2427d20de90fe112864f4f4ab12c5c2eda4926675b805d7889f2bb3ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antiretroviral Therapy, Highly Active - statistics & numerical data</topic><topic>Appointments and Schedules</topic><topic>Female</topic><topic>HIV Infections - blood</topic><topic>HIV Infections - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Text Messaging</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Lizárraga, Iván Renato André Condori</creatorcontrib><creatorcontrib>Alvirio, Luis Alberto Menacho</creatorcontrib><creatorcontrib>Pérez-Lu, José Enrique</creatorcontrib><creatorcontrib>Cavagnaro, César Cárcamo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista peruana de medicina experimental y salud pública</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lizárraga, Iván Renato André Condori</au><au>Alvirio, Luis Alberto Menacho</au><au>Pérez-Lu, José Enrique</au><au>Cavagnaro, César Cárcamo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Text messaging to improve patient adherence in haart: randomized controlled trial</atitle><jtitle>Revista peruana de medicina experimental y salud pública</jtitle><addtitle>Rev Peru Med Exp Salud Publica</addtitle><date>2019-07</date><risdate>2019</risdate><volume>36</volume><issue>3</issue><spage>400</spage><epage>407</epage><pages>400-407</pages><eissn>1726-4642</eissn><abstract>To assess the efficacy of a text messaging (SMS) strategy to improve appointment attendance, treatment adherence, and biological markers (viral load and CD4) in continuous patients with high activity antiretroviral therapy (HAART) who were late to their last scheduled appointment.
A randomized controlled trial implemented in Via Libre, a non-governmental organization (NGO) that provides services to people living with human immunodeficiency virus (HIV) in Lima, Peru, was conducted, where 166 follow-up patients were randomized: 82 participants received SMS for six months and 84 participants received standard care.
Patients in the intervention group: 93.9% were men and had a median of 5.1 years in HAART; in the control group: 94.1% were men and a median of 5.3 years in HAART. In the intervention group, patients attended their scheduled medical appointments more frequently than those in the control group (RR=1.89, 95% CI 1.21-2.97) during the six months of intervention. Comparing the viral load level and CD4 level, no differences were found (p=0.930 and p=0.905, respectively). Adherence to treatment measured by self-report was higher in the intervention group (p<0.001).
The results of this study suggest that sending SMS for six months may improve appointment attendance and adherence to treatment in continuing patients on HAART.</abstract><cop>Peru</cop><pmid>31800931</pmid><doi>10.17843/rpmesp.2019.363.4139</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1726-4642 |
| ispartof | Revista peruana de medicina experimental y salud pública, 2019-07, Vol.36 (3), p.400-407 |
| issn | 1726-4642 |
| language | spa |
| recordid | cdi_proquest_miscellaneous_2322138031 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adolescent Adult Antiretroviral Therapy, Highly Active - statistics & numerical data Appointments and Schedules Female HIV Infections - blood HIV Infections - drug therapy Humans Male Medication Adherence - statistics & numerical data Text Messaging Young Adult |
| title | Text messaging to improve patient adherence in haart: randomized controlled trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T13%3A47%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Text%20messaging%20to%20improve%20patient%20adherence%20in%20haart:%20randomized%20controlled%20trial&rft.jtitle=Revista%20peruana%20de%20medicina%20experimental%20y%20salud%20p%C3%BAblica&rft.au=Liz%C3%A1rraga,%20Iv%C3%A1n%20Renato%20Andr%C3%A9%20Condori&rft.date=2019-07&rft.volume=36&rft.issue=3&rft.spage=400&rft.epage=407&rft.pages=400-407&rft.eissn=1726-4642&rft_id=info:doi/10.17843/rpmesp.2019.363.4139&rft_dat=%3Cproquest_pubme%3E2322138031%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2322138031&rft_id=info:pmid/31800931&rfr_iscdi=true |